Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy

医用大麻、新兴成年人和社区:连接健康和政策

基本信息

  • 批准号:
    10439715
  • 负责人:
  • 金额:
    $ 81.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The rising number of individuals with legal access to marijuana for medical and/or recreational use is arguably the most profound change in drug policy in the past 20 years given the potential impact on public health. California, one of 28 states that authorized marijuana for medical use since 1996, became the eighth medical marijuana state to legalize marijuana for recreational use following the passage of the Adult Use of Marijuana Act (AUMA) in 2016. No research has studied the real-time transition from a medical to a recreational environment and its impact on young adult marijuana users since states began legalizing marijuana for recreational use in 2012. Furthermore, no study has examined the impact of legalization for recreational use on 18 to 20 year olds – a group eligible for medical use but prohibited from recreational use in all legal states. Our long-term goal in this renewal of a current R01 is to inform public policy with findings on safer and controlled use of marijuana among young adults in an environment where marijuana is legal for recreational use. Our objective here is to determine the impact of legalization on young adult marijuana users (18 to 30 year olds) by continuing the study of a cohort of young adults – 210 medical marijuana patients (MMP), 156 non-patient marijuana users (NPU) - recruited in Los Angeles, CA in 2014-15 while also enrolling a new cohort of 150 18 to 20 year old marijuana users. Our central hypothesis is that legalizing marijuana for recreational use will result in increased marijuana use, other drug use, and risk behaviors among young adults, but this increase will vary by patient status (MMP vs. NPU) and orientation towards marijuana use, i.e., medicinal vs. recreational. Our rationale for the proposed research is that renewing a current R01 will offer the unique opportunity to: analyze marijuana use, other drug use, and risk behaviors on a cohort of young adult marijuana users continuously collected both before and after legalization in California; and recruit a new underage cohort of marijuana users for comparative purposes. Guided by preliminary data from the current R01, the central hypothesis will be tested by pursuing three specific aims: 1) Determine the impact of marijuana legalization on trajectories of marijuana use, including high-potency forms, e.g., dabs, edibles, among MMP and NPU (aged 21 to 30); 2) Determine the impact of marijuana legalization on patterns of other drug use and risk behaviors among medicinal and recreational users (aged 21 to 30); and 3) Determine the impact of marijuana legalization on attitudes and patterns of marijuana use among a newly recruited cohort of underage young adults (aged 18 to 20). The approach is innovative because it uses an interrupted time series design to study the effects of legalizing marijuana on young adults, includes both legal and non-legal recreational users, and includes medicinal orientation of marijuana use among recreational users in a fully legal context. The proposed research is significant since the public health impact of legalizing marijuana for recreational use among young adults is unknown.
项目总结/摘要 越来越多的人法律的获得大麻用于医疗和/或娱乐用途, 考虑到对公众的潜在影响,这可以说是过去20年来毒品政策最深刻的变化。 健康加州是自1996年以来批准大麻用于医疗用途的28个州之一,成为第八个州 医用大麻国家合法化大麻娱乐用途后,成人使用的通过, 2016年《海事法》(AUMA)。没有研究研究过从医疗到医疗的实时过渡。 娱乐环境及其对年轻成人大麻使用者的影响,因为国家开始合法化 2012年用于娱乐的大麻此外,没有研究探讨合法化对 18至20奥尔兹的娱乐用途-符合医疗用途但禁止娱乐用途的群体 在所有法律的州。我们对当前R 01进行更新的长期目标是为公共政策提供调查结果 在大麻法律的环境中, 用于娱乐用途。我们的目标是确定合法化对青少年大麻的影响 使用者(18至30奥尔兹)通过继续研究一组年轻人- 210医用大麻 2014-15年在加利福尼亚州洛杉矶招募了156名非患者大麻使用者(NPU), 还招募了150名18至20岁的大麻使用者。我们的核心假设是, 将大麻合法化用于娱乐用途将导致大麻使用增加,其他药物使用和风险增加 年轻人的行为,但这种增加将因患者状态(MMP与NPU)和取向而异 大麻的使用,即,药用vs.娱乐我们提出这项研究的理由是, 更新当前的R 01将提供独特的机会:分析大麻使用,其他药物使用和风险 一组年轻的成年大麻使用者的行为, 在加州合法化;并招募一个新的未成年大麻使用者群体进行比较。 在当前R 01的初步数据的指导下,将通过以下三个方面来检验中心假设: 具体目标:1)确定大麻合法化对大麻使用轨迹的影响,包括 高效形式,例如,在MMP和NPU(21至30岁)中, 大麻合法化对其他药物使用模式和医疗和娱乐之间的风险行为 使用者(21至30岁);和3)确定大麻合法化对态度和模式的影响, 在新招募的未成年年轻人(18至20岁)中使用大麻。该方法是 创新,因为它使用中断的时间序列设计来研究大麻合法化对 年轻成人,包括法律的和非法律的娱乐使用者,包括 在完全法律的背景下,娱乐性吸食者吸食大麻。这项研究意义重大,因为 年轻人娱乐用大麻合法化对公共卫生的影响尚不清楚。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen E Lankenau其他文献

S144 - “If You Go in With a Plan and a Goal, It Can Be Therapeutic”: A Qualitative Exploration of Psychedelic Use Among Emerging Adult Cannabis Users in Los Angeles
S144 - “如果你带着计划和目标去使用,它可能具有治疗作用”:对洛杉矶新兴成年大麻使用者中迷幻剂使用的定性探索
  • DOI:
    10.1016/j.drugalcdep.2024.111564
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Bridgid Conn;Meagan Suen;Kaia L. Sheean;Janna Ataiants;Ekaterina Fedorova;Stephen E Lankenau;Carolyn F. Wong
  • 通讯作者:
    Carolyn F. Wong

Stephen E Lankenau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen E Lankenau', 18)}}的其他基金

UnityPhilly Response App for Overdose Reversal: Assessing Citywide Effectiveness and Sustainability
UnityPhilly 逆转用药过量响应应用程序:评估全市范围的有效性和可持续性
  • 批准号:
    10585638
  • 财政年份:
    2023
  • 资助金额:
    $ 81.23万
  • 项目类别:
Piloting a naloxone intervention in an emergency response community to reduce opioid overdoses in Philadelphia
在费城的应急响应社区试点纳洛酮干预措施,以减少阿片类药物过量
  • 批准号:
    9403417
  • 财政年份:
    2017
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8685230
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    9228355
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8813547
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
医用大麻、新兴成年人和社区:连接健康和政策
  • 批准号:
    10207574
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8503943
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8816603
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
医用大麻、新兴成年人和社区:连接健康和政策
  • 批准号:
    9793996
  • 财政年份:
    2013
  • 资助金额:
    $ 81.23万
  • 项目类别:
Evaluation of Overdose Prevention Programs for Injection Drug Users
注射吸毒者过量预防方案的评价
  • 批准号:
    7686401
  • 财政年份:
    2009
  • 资助金额:
    $ 81.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了